Samuel H. Zuvekas, PhD

Agency for Healthcare Research and Quality, Rockville, Maryland

JCP
Trends in Benzodiazepine Prescribing to Adults in the United States
Original Research

February 18, 2026

Between 2018 and 2022, annual benzodiazepine use by US adults decreased from 4.7% to 3.4%.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe